Patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation experienced ...

Pembrolizumab (Keytruda) given before and after surgery to supplement adjuvant therapy improved responses and survival in ...

Researchers at the Viterbi School of Engineering published a study at the beginning of April detailing their work using ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Some people with early-stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

A new, small cancer study may give hope to patients with solid tumors in the stomach, esophagus or rectum. The standard ...

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, ...

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the ...